CAN FITE BIOPHARMA LTD-ADR (CANF) Stock Cash Flow
NYSEARCA:CANF - American Stock Exchange - US13471N3008 - ADR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.37M | -7.63M | -10.17M | -12.62M | -14.44M | |||
| Depreciation Amortization | 8.00K | 15.00K | 14.00K | 14.00K | 12.00K | |||
| Change In Working Capital | -586.00K | -943.00K | -1.30M | 2.43M | 443.00K | |||
| Interest Paid | N/A | 0.00 | 0.00 | 18.00K | 23.00K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 518.00K | 122.00K | 659.00K | 313.00K | 1.93M | |||
| OPERATING CASH FLOW | -7.43M | -8.44M | -10.80M | -9.86M | -12.06M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.00K | -2.00K | -9.00K | -11.00K | -26.00K | |||
| Other Investing Activity | 6.00M | 500.00K | 9.51M | -14.50M | N/A | |||
| INVESTING CASH FLOW | 6.00M | 498.00K | 9.50M | -14.51M | -26.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 2.62M | 9.14M | 0.00 | 20.46M | 17.68M | |||
| FINANCING CASH FLOW | 2.62M | 9.14M | 0.00 | 20.46M | 17.68M | |||
| Exchange Rate Effect | N/A | 98.00K | -113.00K | 34.00K | -23.00K | |||
| CHANGE IN CASH | 1.26M | 1.30M | -1.41M | -3.88M | 5.57M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.43M | -8.44M | -10.80M | -9.86M | -12.06M | |||
| Capital Expenditure | -4.00K | -2.00K | -9.00K | -11.00K | -26.00K | |||
| FREE CASH FLOW | -7.43M | -8.44M | -10.81M | -9.87M | -12.09M | |||
All data in USD